Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnicorn Asset Management Regulatory News (UAV)

Share Price Information for Unicorn Asset Management (UAV)

Share Price is delayed by 15 minutes
Get Live Data
68.00    0.00 (0.00%)
Bid:
65.00
Ask:
71.00
Spread: 6.00 (9.231%)
Market Cap: £175.12m
UAV Live PriceLast checked at - London Stock Exchange

Intraday Unicorn Asset Management Share Chart

Portfolio Update

28 Nov 2025 13:34

RNS Number : 4934J
Unicorn AIM VCT PLC
28 November 2025
 

Unicorn AIM VCT PLC

LEI: 21380057QDV7D34E9870

Portfolio Update

 

The Directors of Unicorn AIM VCT plc (the "Company") are pleased to announce that the Company, together with other shareholders of Hasgrove Limited ("Hasgrove"), has entered into an agreement with Castik Capital S.à r.l. ("Castik") in connection with Castik's proposed acquisition of a majority stake in Hasgrove.

 

As part of the transaction, Unicorn AIM VCT plc, together with the former Chairman and members of the executive management team, will realise a portion of their investment for cash and, alongside Castik, will become shareholders in a new holding company established to acquire Hasgrove (the "Newco").

 

Hasgrove is currently the largest holding in the Company's portfolio and was most recently valued at £46.7 million in the Company's Net Asset Value ("NAV") update released as at 31 October 2025. Subject to completion of the transaction, receipt of the cash consideration and the finalisation of valuations, the Board expects the NAV to be materially higher than that reported as at 31 October 2025. In connection with the Transaction, the Company will conduct a fair value review of its interest in Newco and publish an updated NAV as soon as practicable.

 

The Company expects to receive total net proceeds of approximately £87 million from the transaction. Of this amount, approximately £22 million is expected to be settled through the issuance of shares in Newco, with the remaining £65m expected to be received in cash (in each case subject to completion adjustments). The Board will consider whether to declare a special dividend following completion and once final proceeds have been received, with further details (including quantum and timing) to be announced in due course.

 

Unicorn Asset Management Limited ("Unicorn"), the Company's Investment Manager, commented:

 

"Unicorn has been proud to partner with Hasgrove since backing the business at IPO in 2006, providing strategic input and working closely with the leadership team throughout its journey. This transaction delivers another significant realisation for Unicorn AIM VCT plc shareholders, crystallising significant value whilst crucially maintaining exposure to what we believe is a high-quality, cash-generative business with strong growth potential. Having engaged closely with both management and Castik, we are confident this partnership represents the right next step and look forward to working together as Hasgrove enters this exciting new chapter."

 

Tim Woodcock, Chair, Unicorn AIM VCT plc. commented:

 

"The Unicorn team have delivered an excellent result in both realising considerable cash proceeds from the investment for the Company's shareholders, and negotiating a deal which enables the VCT to participate in the future growth of Hasgrove"

 

For further information please contact:

 

Investment Manager:

Unicorn Asset Management Limited

Telephone: 020 7253 0889

Email:info@unicornam.com

 

Company Secretary:

ISCA Administration Services Limited

Telephone: 01392 487056

Email:unicornaimvct@iscaadmin.co.uk

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUXVLFLEFLXFBL
Date   Source Headline
14th Feb 20241:36 pmRNSDirector/PDMR Shareholding
14th Feb 202410:23 amRNSIssue of Equity
8th Feb 20243:47 pmRNSOffer for Subscription - Update
7th Feb 20245:43 pmRNSResult of AGM
5th Feb 20243:37 pmRNSNet Asset Value(s)
1st Feb 20242:53 pmRNSInterim Management Statement
26th Jan 202411:47 amRNSOffer for Subscription and Issue of Prospectus
11th Jan 20247:00 amRNSDividend Declaration
9th Jan 202410:39 amRNSNet Asset Value(s)
20th Dec 20233:06 pmRNSDirector Declaration
8th Dec 20237:00 amRNSFinal Results
6th Dec 20233:47 pmRNSNet Asset Value(s)
28th Nov 202310:00 amRNSIntention to launch an Offer
6th Nov 20234:48 pmRNSNet Asset Value(s)
17th Oct 20235:04 pmRNSNet Asset Value(s)
2nd Oct 20239:19 amRNSTotal Voting Rights
25th Sep 20239:18 amRNSTransaction in Own Shares
7th Sep 202311:40 amRNSNet Asset Value(s)
1st Sep 202311:39 amRNSTotal Voting Rights
25th Aug 20239:16 amRNSTransaction in Own Shares
14th Aug 202312:42 pmRNSDirector/PDMR Shareholding
11th Aug 20231:47 pmRNSIssue of Equity under Dividend Reinvestment Scheme
4th Aug 202310:57 amRNSNet Asset Value(s)
1st Aug 202310:19 amRNSTotal Voting Rights
19th Jul 20237:00 amRNSTransaction in Own Shares
7th Jul 20239:12 amRNSNet Asset Value(s)
3rd Jul 202312:23 pmRNSTotal Voting Rights
9th Jun 20234:11 pmRNSTransaction in Own Shares
6th Jun 20232:18 pmRNSHolding(s) in Company
5th Jun 20234:43 pmRNSNet Asset Value(s)
31st May 20237:00 amRNSHalf-year Report
5th May 20239:20 amRNSNet Asset Value(s)
6th Apr 202310:53 amRNSNet Asset Value(s)
3rd Apr 202310:25 amRNSTotal Voting Rights
10th Mar 20234:32 pmRNSTransaction in Own Shares
3rd Mar 20235:36 pmRNSNet Asset Value(s)
1st Mar 20239:52 amRNSTotal Voting Rights
22nd Feb 20234:04 pmRNSDirector/PDMR Shareholding
22nd Feb 20239:14 amRNSIssue of Equity
21st Feb 202311:43 amRNSNet Asset Value(s)
14th Feb 202312:42 pmRNSIssue of Equity
13th Feb 20234:53 pmRNSTransaction in Own Shares
7th Feb 20236:14 pmRNSResult of AGM
6th Feb 20235:30 pmRNSOffer for Subscription Update
6th Feb 202312:02 pmRNSOffer for Subscription – Update
6th Feb 20237:00 amRNSNet Asset Value(s)
1st Feb 202310:34 amRNSTotal Voting Rights
30th Jan 202311:24 amRNSInterim Management Statement
24th Jan 202312:09 pmRNSOffer for Subscription and Issue of Prospectus
16th Jan 20239:51 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.